Author: Staff

The co-owners of an addiction treatment center in Florida have both pleaded guilty to charges linking them to three patient overdose deaths, local news source the Palm Beach Post reported July 23.

Smitta Patel, MD, a psychiatrist at the UCLA Semel Institute for Neuroscience and Human Behavior, is joining VyTrac Health's medical advisory board. 

Josh Guillory, mayor and president of Lafayette, La., checked himself into a rehabilitation facility for treatment of possible alcohol addiction and post-traumatic stress disorder, local ABC affiliate KATC3 reported July 25.

U.S. News & World Report released its list of the best hospitals for psychiatry July 26, with Boston-based McLean Hospital, Baltimore-based Johns Hopkins Hospital and Massachusetts General Hospital, also in Boston, ranking in the top three.

Medical technology company Neuronetics will be the exclusive supplier of transcranial magnetic stimulation equipment used in the mental health treatment network of Arkansas-based Alleviant Health, Neuronetics said July 25.

In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21.

Children are more likely to have an anxiety disorder if their same-sex parent has one, a study published by JAMA Open Network found. 

Telehealth at-home ketamine therapy sessions are a safe and "incredibly effective" treatment for depression and anxiety, clinicians in charge of a recent study published in Journal of Affective Disorders reported.

Sens. Patty Murray and Ron Wyden of Washington and Oregon, respectively, are launching an investigation into abuse of children with special needs and mental health issues at residential treatment centers, NBC reported July 22.

The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week.